Physician profile
Timothy Gajewski
NPI 1841239233
$14,024.46
in general payments reported to CMS, 2019-2025
50 companies · $3,937 in 2025
The $3,937 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,093 · 2020: $350 · 2021: $1,439 · 2022: $2,276 · 2023: $3,162 · 2024: $1,767 · 2025: $3,937.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,229 · Travel and Lodging: $3,362 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,229.13 |
| Travel and Lodging | $3,362.10 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $274.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $3,470.19 | 2020-2024 | Altis, Porges Coloplast, Saffron |
| Procept Biorobotics Corporation | $3,158.14 | 2023-2025 | Aquabeam Robotic System |
| Boston Scientific Corporation | $1,161.83 | 2019-2024 | Ams 700, Ams 700 Cxr Rte Kit, Rezum Generator |
| Clinical Laserthermia Systems Americas INC. | $725.22 | 2023-2024 | Mobile Laser Unit |
| Abbvie INC. | $606.10 | 2019-2025 | |
| Teleflex LLC | $451.47 | 2021-2025 | Barrigel, Urolift |
| Endo Pharmaceuticals INC. | $432.95 | 2019-2024 | Xiaflex |
| Axonics, INC. | $343.68 | 2022-2024 | Axonics |
| Sumitomo Pharma America, INC. | $308.65 | 2023-2025 | Gemtesa, Orgovyx |
| Merz North America, INC. | $305.49 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $260.67 | 2020-2025 | Prolaris |
| Medtronic, INC. | $222.18 | 2025 | Interstim |
| Astellas Pharma US INC | $204.87 | 2019-2023 | Myrbetriq |
| Urovant Sciences INC | $186.59 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $150.36 | 2019-2023 | Provenge |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Gajewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.